The worldwide biotechnology industry was worth USD 752.88 billion in 2020, and it is predicted to increase at a 15.83 percent compound annual growth rate (CAGR) from 2021 to 2028. Because of the rise of the biotechnology sector in developing nations like India and China, the market is being driven by favourable government initiatives. Government activities are aimed at streamlining the medication regulatory pathway, standardising clinical studies, enhancing reimbursement policies, and expediting the product approval process, all of which will provide the industry with lucrative growth potential. The development of therapeutic proteins and other medications has been aided by the growing use of biotech solutions. The need for medication discovery and development has grown as the prevalence of chronic diseases has increased. Due to the broad nature of the application, it is being employed more frequently in various industrial areas. The increasing use of organic products in agriculture is also contributing to market expansion.
Title : Molecular therapeutics for Chronic Obstructive Pulmonary Disease
Yong Xiao Wang, Albany Medical College, United States
Title : Biotech scale-up: Bioengineering imperatives in biomanufacturing
Murray Moo Young, University of Waterloo, Canada
Title : A Real BandAIdâ„¢: Incorporating Artificial Intelligence (AI) into Biomaterials and Medicine
Thomas J Webster, Hebei University of Technology, China
Title : Modulation of alternative splicing as a novel therapeutic avenue in cancer
Sebastian Oltean, University of Exeter Medical School, United Kingdom
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, resulting in eradication of implanted orthotopic tumors with no side effects
AC Matin, Stanford University School of Medicine, United States
Title : Antimicrobial electrospun fibrous scaffolds and their potential use as wound dressings
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico